Okayama Central Hospital

What Okayama Central Hospital does

Okayama Central Hospital (社会医療法人鴻仁会 岡山中央病院) is a multi-specialty acute-care hospital founded in 1951 and operated by Social Medical Corporation Kohjin Kai, headquartered in Okayama-shi, Okayama Prefecture, Japan. It serves the general patient population of Okayama Prefecture and surrounding regions across 16+ clinical departments including Urology, Obstetrics/Gynecology, Orthopedics with spine surgery, Internal Medicine, Surgery, Cardiovascular Surgery, Neurology, Neurosurgery, Radiology, Emergency Medicine, Anesthesiology, Nephrology, Rehabilitation, Palliative Care, Gastroenterology, and Vascular Surgery. The hospital is anchored by several long-running specialty centers: a Dialysis Center (50+ years of operation), a Women's Medical Center (25+ years), a Radiation Cancer Treatment Center, and a 24/7 Birth Center offering painless delivery. A satellite preventive-medicine facility, Central Clinic Ijima, supports screening and outpatient services.

The hospital has invested in advanced clinical technology including Japan's first domestically produced hinotori Surgical Robot System (deployed March 2023, first in Okayama Prefecture), Vero4DRT radiation therapy for prostate cancer, EMSELLA HIFEM equipment for urinary incontinence (May 2024), and DWIBS-method painless MRI breast cancer screening (August 2019) developed in partnership with Tokai University. It is also co-developing a non-carcinogenic surgical skin marker with Kindai University and Hayakawagom Co., Ltd. (patent filed April 2023). AI deployment is limited to image-assist support in breast ultrasound examinations.

Revenue is generated primarily through fee-for-service medical care reimbursed under Japan's national universal health insurance system, supplemented by self-pay services such as DWIBS MRI breast screening (21,000 yen), EMSELLA sessions (7,700 yen), dynamic infusion therapy for pain (30,000-50,000 yen), and laser varicose vein treatment. The hospital runs a Ministry of Health-registered clinical training program (recruiting for 2027), operates a regular healthcare-professional seminar series, and reaches patients via its website, YouTube channel, Instagram (Birth Center), quarterly PR magazine 'Relation', and earned media in the Sanyo Shimbun health guide. As a social medical corporation, ownership is non-profit and not exposed to private equity or public market capital.

Name

Okayama Central Hospital

Legal name

社会医科大学 鴻仁会 岡山 Central Hospital

Website

https://kohjin.ne.jp

Company type

Private

Founded year

1951

Operating status

Operating

Short description

Okayama Central Hospital is a multi-specialty acute-care hospital in Okayama, Japan, operated by Social Medical Corporation Kohjin Kai since 1951. It serves Okayama Prefecture residents across urology, OB/GYN, orthopedics, dialysis, radiation oncology, and emergency care through its main campus and satellite Central Clinic Ijima.

Ownership category

akta.pro rank

Product category

Multi-Specialty Hospital Services

NAICS

General Medical and Surgical Hospitals (62211)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Orthopedic & Spine Surgery Centers (HLAFAIAG), Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)

Keywords

• Multi-specialty hospital services
• Radiation oncology treatment
• Urological surgical services
• Obstetrics gynecology care
• Dialysis rehabilitation services

Headquarters

HQ city

Okayama-shi

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive medical services including outpatient consultations, inpatient care, surgical procedures, diagnostic imaging, radiation therapy, dialysis treatments, and rehabilitation services. Services are primarily covered under Japan's national health insurance system with patient co-payments.
2. Self-Pay/Out-of-Pocket Medical Services: Revenue from optional medical services not covered by national insurance, including DWIBS MRI breast cancer screening (21,000 yen), EMSELLA treatments (7,700 yen per session), and dynamic infusion therapy for pain management.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Okayama Central Hospital is a multi-specialty regional hospital providing comprehensive medical services across urology, obstetrics/gynecology with a dedicated birth center, orthopedics with spine surgery, dialysis, radiation oncology, rehabilitation, and general medicine. It operates specialized centers (Radiation Cancer Treatment Center, Women's Medical Center) and a satellite preventive-medicine clinic (Central Clinic Ijima), offering services from emergency and inpatient care through advanced minimally invasive and robotic surgery to outpatient screening and self-pay diagnostics such as DWIBS MRI breast cancer screening.

Product overview

Okayama Central Hospital is a medical corporation hospital (社会医科大学鴻仁会) offering comprehensive medical services across multiple departments. The hospital operates specialized centers including a Radiation Cancer Treatment Center, Women's Medical Center (ウィミンズメディかがルセンター), and affiliated Central Clinic Ijima. Key services include urology with advanced stone treatment and robotic surgery (hinotori™), obstetrics with 24/7 painless childbirth, orthopedic spine surgery, dialysis, and rehabilitation. The hospital offers innovative diagnostic services such as painless MRI breast cancer screening (DWIBS method), and treatment equipment like EMSELLA® for pelvic floor rehabilitation.

Differentiator

Problem solved

Functional benefit

Brands

• ウィミンズオーガニックセンター (Women's Medical Center): Women's medical center providing comprehensive healthcare services for women across all life stages, celebrating 25 years in 2024.
• 放射線がん治療センター (Radiation Cancer Treatment Center)
• バースセンター (Birth Center)
• 透析センター (Dialysis Center)

Products and services

• Urology Department (泌尿器科) Comprehensive urology service offering treatment for kidney stones, female urological conditions, urinary incontinence, pelvic organ prolapse, and minimally invasive treatment of urological tumors including prostate cancer (HoLEP, robotic prostatectomy, lithotripsy). For patients in Okayama and surrounding areas.
• Obstetrics, Gynecology and Birth Center (産婦人科 / バースセンター)

Quantifiable outcome

• Approximately 80% of kidney stone patients treated with single ESWL session
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Kindai University (近畿大学)coreStrategic or Co-development Partner · 16 October 2023Research collaboration with Kindai University Faculty of Medicine Radiology Department (Prof. Monzen Hajime) and Pediatrics Department (Dr. Miyazaki Kohei) for development of cancer-free surgical skin markers. Joint research team published findings in Radiological Physics and Technology journal. Patent filed jointly with university researchers.
• Hayakawagom Co., Ltd. (早川ゴム株式会社)coreStrategic or Co-development Partner · 16 October 2023Joint development partner for non-carcinogenic surgical skin marker product. Hayakawagom contributed cosmetic material expertise for developing safe skin marker ink meeting pharmaceutical standards. Partnership aims for product commercialization.
• Tokai University (東海大学)coreStrategic or Co-development Partner · 1 August 2019Technology licensing/partnership with Tokai University Radiology Department and Prof. Takahara for DWIBS (Diffusion-weighted Whole body Imaging with Background Suppression) MRI breast cancer screening technology. Prof. Takahara is the original developer of the DWIBS method.
• Kawasaki Medical School General Medical Center (川崎医科大学総合医療センター)minorStrategic or Co-development PartnerReferral and collaborative care partnership for vascular surgery services. Kawasaki Medical School specialists provide consultations and treatments at Okayama Central Hospital for complex vascular cases.
• Tokuno Clinic (オクノクリニック)minorStrategic or Co-development PartnerLicensing partnership for dynamic infusion therapy (動注治療) for chronic pain treatment. Developed by Dr. Okuno, the hospital received training and guidance under a license agreement to offer this treatment modality.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kawasaki Medical School Hospital: Teaching hospital of Kawasaki Medical School located within the same Okayama medical region, offering a comparable multi-specialty portfolio. Already a formal collaborative partner to Okayama Central for vascular surgery referrals, making it the closest direct peer in terms of geography, scale, and clinical capability.
• Kurashiki Central Hospital: Large regional acute-care hospital in neighboring Kurashiki (Okayama Prefecture) with broad specialty coverage and a reputation for advanced care. Highly comparable to Okayama Central as a regional Japanese general hospital competing for the same prefectural patient pool.
• Saiseikai Okayama Hospital: Social medical corporation hospital in Okayama providing general and specialty care. Closely mirrors Okayama Central's ownership type (social medical corporation) and service model, making it a strong direct peer for operating comparisons.
• Japanese Red Cross Okayama Hospital: Regional general hospital operated by the Japanese Red Cross in Okayama City, offering comparable multi-specialty inpatient and outpatient services. Direct peer in terms of regional coverage, payer mix (national insurance), and scale.

Broad incumbents

• Okayama University Hospital: Major academic medical center in Okayama City offering deep subspecialty coverage and clinical research. Represents the incumbent academic competitor that anchors the most complex cases in the same catchment area as Okayama Central.
• Toranomon Hospital: Large urban Japanese general hospital with strong specialty centers and a focus on advanced equipment. Comparable as a benchmark for a multi-specialty Japanese hospital pursuing technology differentiation.
• Kameda Medical Center: Large private Japanese hospital group with strong technology adoption and specialty depth. Comparable in its push toward advanced medical equipment and multi-specialty integration, and useful as a benchmark for technology-led regional hospital strategy.
• Sapporo Medical University Hospital: Academic medical center in Hokkaido with comprehensive specialty services. Comparable in its integration of clinical training, advanced technology, and multi-specialty care within a Japanese regional academic context.
• St. Luke's International Hospital: Urban Tokyo general hospital known for patient-centered care, advanced screening offerings, and premium services. Comparable in its investment in self-pay screening programs and concierge-style patient experience to Okayama Central's preventive medicine direction.

Regional players

• Hiroshima City Hiroshima Citizens Hospital: Municipal general hospital in the adjacent Chugoku region. Comparable in scale, public-pay orientation, and broad specialty portfolio, and a useful reference for regional Japanese hospital operations outside the Okayama market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCpWWAdjJi7zOOQXutNdPWEw
• Instagraminstagram.com/okachu_birthcenter

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Okayama Central Hospital